GOOD NEWS FOR AMD PATIENTS
* Health and Long-Term Care Minister Tony Clement announced last month that Ontario will provide more than $20 million in funding for the treatment of wet age-related macular degeneration (AMD) with the drug verteporfin (Visudyne). The government of Ontaria will now cover the Visudyne treatment as an insured service under the Ontario Health Insurance Plan. The Ministry of Health will provide hospitals with the funds to administer this program retroactive to April 1.
It is expected that an average of 1,200 people across the province will benefit from this treatment each year.
Copyright Boucher Communications, Inc. Jun 2002
Provided by ProQuest Information and Learning Company. All rights Reserved
Contact
Home
A
Hydrocodone